Skip to content
DataLookout
Menu

NCT07270679

Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy for Cryopreservation

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 31 days later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 8 words
    • Primary completion pushed from Oct 2026 to Dec 2026
    • Study completion pushed from Dec 3, 2026 to Feb 2027
    • Study title revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

To compare the mutational status of genes involved in DNA repair mechanisms in ovarian tissue fragments from women who underwent ovarian cryopreservation and completed chemotherapy treatment for lymphoma or breast cancer
Timeframe: At least 6 months after the end of chemotherapy

Secondary (1)

To compare the mutational load of altered genes between women who developed POI and those who did not after undergoing chemotherapy

Sites

1 site in 1 country

  • IRCCS Azienda Ospedaliero-Universitaria di BolognaBologna, Bologna, Italy